Small molecule inhibitors of PSD95-nNOS protein-protein interactions as novel analgesics.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuropharmacology

• Publication date

  2015-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.neuropharm.2015.05.038PMID 26071110PMCID PMC4539046
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.

  2015cited by this paper
• Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.

  2013cited by this paper
• The nNOS-p38MAPK Pathway Is Mediated by NOS1AP during Neuronal Death

  2013cited by this paper
• Small-Molecule Inhibitors at the PSD-95/nNOS Interface have Antidepressant-Like Properties in Mice

  2013cited by this paper
• The future of pain research, education, and treatment: a summary of the IOM report “Relieving pain in America: a blueprint for transforming prevention, care, education, and research”

  2012cited by this paper
• Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.

  2012cited by this paper
• The mechanisms of microgliosis and pain following peripheral nerve injury.

  2012cited by this paper
• Excitotoxic neuroprotection and vulnerability with CaMKII inhibition.

  2011cited by this paper
• Animal models of neuropathic pain

  2011cited by this paper
• The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.

  2011cited by this paper
• Perturbing PSD-95 Interactions With NR2B-subtype Receptors Attenuates Spinal Nociceptive Plasticity and Neuropathic Pain

  2011cited by this paper
• Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice

  2011cited by this paper
• Targeting N-methyl-D-aspartate receptors for treatment of neuropathic pain

  2011influential reference
• Research progress on neurobiology of neuronal nitric oxide synthase

  2011cited by this paper
• Treatment of cerebral ischemia by disrupting ischemia-induced interaction of nNOS with PSD-95

  2010influential reference
• Nitric oxide synthase modulates CFA-induced thermal hyperalgesia through cytokine regulation in mice

  2010cited by this paper
• The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.

  2009cited by this paper
• Disruption of nNOS‐PSD95 protein–protein interaction inhibits acute thermal hyperalgesia and chronic mechanical allodynia in rodents

  2009influential reference
• Cellular and molecular mechanisms of pain.

  2009cited by this paper
• Nitric oxide and pain: ‘Something old, something new’

  2009cited by this paper
• Chemotherapy‐induced neuropathy

  2008cited by this paper
• NS21: re-defined and modified supplement B27 for neuronal cultures.

  2008influential reference
• A Mechanism for Ca2+/Calmodulin-Dependent Protein Kinase II Clustering at Synaptic and Nonsynaptic Sites Based on Self-Association

  2005cited by this paper
• NMDA receptor subunit NRI and postsynaptic protein PSD-95 in hippocampus and orbitofrontal cortex in schizophrenia and mood disorder.

  2005cited by this paper
• Effect of genetic knockout or pharmacologic inhibition of neuronal nitric oxide synthase on complete Freund's adjuvant‐induced persistent pain

  2005cited by this paper
• Bidirectional Regulation of Neuronal Nitric-oxide Synthase Phosphorylation at Serine 847 by the N-Methyl-d-aspartate Receptor*

  2004cited by this paper
• Antinociceptive effect in mice of intraperitoneal N‐methyl‐d‐aspartate receptor antagonists in the formalin test

  2003influential reference
• Effects of chronic dizocilpine on acute pain and on mRNA expression of neuropeptides and the dopamine and glutamate receptors.

  2003cited by this paper
• A Conditional Deletion of the NR1 Subunit of the NMDA Receptor in Adult Spinal Cord Dorsal Horn Reduces NMDA Currents and Injury-Induced Pain

  2003cited by this paper
• Energetic determinants of internal motif recognition by PDZ domains.

  2001cited by this paper
• Involvement of NMDA receptors in the analgesic properties of psychotridine.

  2001influential reference
• Formation of nNOS/PSD-95 PDZ dimer requires a preformed beta-finger structure from the nNOS PDZ domain.

  2000cited by this paper
• Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses.

  2000influential reference
• The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

  2000cited by this paper
• The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses

  2000cited by this paper
• Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein.

  1999cited by this paper
• PSD-95 Assembles a Ternary Complex with theN-Methyl-d-aspartic Acid Receptor and a Bivalent Neuronal NO Synthase PDZ Domain*

  1999cited by this paper
• Differential contribution of the two phases of the formalin test to the pattern of c‐fos expression in the rat spinal cord: studies with remifentanil and lidocaine

  1997cited by this paper
• Role of spinal gamma-aminobutyric acidA receptors in formalin-induced nociception in the rat.

  1997cited by this paper
• Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat.

  1992cited by this paper
• The formalin test: an evaluation of the method

  1992influential reference
• Evidence for a central component of post-injury pain hypersensitivity

  1983cited by this paper
• Available online at www.sciencedirect.com Critical Review Central Sensitization: A Generator of Pain Hypersensitivity by Central Neural Plasticity

  year unknowncited by this paper
• Cellular Neuroscience Mini Review Article Mechanisms of Nos1ap Action on Nmda Receptor-nnos Signaling Nmdar-driven Nnos Signaling and the Involvement of Psd95

  year unknowncited by this paper

• Acetaminophen attenuates pathological pain through a mechanism that requires CB1 cannabinoid receptors and the enzyme diacylglycerol lipase in mice

  2025cites this paper
• Uncoupling toxic NO signaling: Progress, challenges, and therapeutic promise of disrupting the PSD-95/nNOS protein-protein interaction.

  2025cites this paper
• Metabolite classification through novel metabolomics framework reveals mechanism underlying the therapeutic effects of PSD95-nNOS blockade for post-stroke depression

  2025cites this paper
• Agmatine inhibits NMDA receptor-mediated calcium transients in mouse spinal cord dorsal horn via intact PSD95-nNOS signaling.

  2024cites this paper
• Post-stroke effects of IC87201 on neurobehavioral function and brain injuries: A stereological study

  2024cites this paper
• Exploring protein-protein interactions for the development of new analgesics

  2024cites this paper
• PSD-95 Protein: A Promising Therapeutic Target in Chronic Pain

  2024cites this paper
• Combinatorial therapy with sub-effective Ro25-6981 and ZL006 ameliorates depressive-like behavior in single or combined stressed male mice.

  2024cites this paper
• Ion Current Rectification Activity Induced by Boron Hydride Nanosheets to Enhance Magnesium Analgesia.

  2024cites this paper
• Cannabidiol induces systemic analgesia through activation of the PI3Kγ/nNOS/NO/KATP signaling pathway in neuropathic mice. A KATP channel S-nitrosylation-dependent mechanism.

  2024cites this paper
• Discovery of benzyloxy benzamide derivatives as potent neuroprotective agents against ischemic stroke.

  2023cites this paper
• IC87201, a PSD-95/nNOS Inhibitor, Ameliorates Heart Rate Variability in the Rat Model of Middle Cerebral Artery Occlusion

  2023cites this paper
• nNOS and Neurological, Neuropsychiatric Disorders: A 20-Year Story

  2023cites this paper
• Enhanced AMPAR-dependent synaptic transmission by S-nitrosylation in the vmPFC contributes to chronic inflammatory pain-induced persistent anxiety in mice

  2022cites this paper
• The antipsychotic aripiprazole induces peripheral antinociceptive effects through PI3Kγ/NO/cGMP/KATP pathway activation

  2022cites this paper
• Inhibition of PSD95‐nNOS protein–protein interactions decreases morphine reward and relapse vulnerability in rats

  2022cites this paper
• NMDARs mediate peripheral and central sensitization contributing to chronic orofacial pain

  2022cites this paper
• A pain killer without analgesic tolerance designed by co-targeting PSD-95-nNOS interaction and α2-containning GABAARs

  2021cites this paper
• Quantitative Proteomics Analysis of Susceptibility and Resilience to Stress in a Rat model of PTSD.

  2021cites this paper
• PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor disorder associated with neuropathic pain model.

  2021cites this paper
• Targeting PSD95/nNOS by ZL006 alleviates social isolation-induced heightened attack behavior in mice

  2021cites this paper
• Intermolecular diastereoselective annulation of azaarenes into fused N-heterocycles by Ru(II) reductive catalysis

  2021cites this paper
• A peripheral CB2 cannabinoid receptor mechanism suppresses chemotherapy-induced peripheral neuropathy: evidence from a CB2 reporter mouse

  2021cites this paper
• A Compound Mitigates Cancer Pain and Chemotherapy-Induced Neuropathic Pain by Dually Targeting nNOS-PSD-95 Interaction and GABAA Receptor

  2021cites this paper
• Bidirectional protein–protein interactions control liquid–liquid phase separation of PSD-95 and its interaction partners

  2021cites this paper
• Role of Neuronal Nitric Oxide Synthase on Cardiovascular Functions in Physiological and Pathophysiological States.

  2020cites this paper
• Prolonged Use of NMDAR Antagonist Develops Analgesic Tolerance in Neuropathic Pain via Nitric Oxide Reduction-Induced GABAergic Disinhibition

  2020cites this paper
• PCC-0105002, a novel small molecule inhibitor of PSD95-nNOS protein-protein interactions, attenuates neuropathic pain and corrects motor coordination-associated side effects in neuropathic pain model.

  2020cites this paper
• Inhaled Cannabis Suppresses Chemotherapy-Induced Neuropathic Nociception by Decoupling the Raphe Nucleus: A Functional Imaging Study in Rats.

  2020cites this paper
• nNOS-mediated protein-protein interactions: promising targets for treating neurological and neuropsychiatric disorders

  2020cites this paper
• Disrupting nNOS-PSD95 Interaction Improves Neurological and Cognitive Recoveries after Traumatic Brain Injury.

  2020cites this paper
• PCC0208009, an indirect IDO1 inhibitor, alleviates neuropathic pain and co-morbidities by regulating synaptic plasticity of ACC and amygdala.

  2020cites this paper
• Catalytic Conversion of N-Heteroaromatics to Functionalized Arylamines by Merging Hydrogen Transfer and Selective Coupling

  2020cites this paper
• Shank3 contributes to neuropathic pain by facilitating the SNI-dependent increase of HCN2 and the expression of PSD95.

  2020cites this paper
• Analgesic effects of astilbin partially via calcium channels through regulation on CaMKII

  2019cites this paper
• Alterations in brain neurocircuitry following treatment with the chemotherapeutic agent paclitaxel in rats

  2019cites this paper
• RGS4 Maintains Chronic Pain Symptoms in Rodent Models

  2019cites this paper
• nNOS-PSD95 interactions activate the PKC-ε isoform leading to increased GluN1 phosphorylation and the development of neuropathic mechanical allodynia in mice.

  2019cites this paper
• Brain permeant and impermeant inhibitors of fatty‐acid amide hydrolase suppress the development and maintenance of paclitaxel‐induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro

  2019cites this paper
• PDZ Domains as Drug Targets

  2019cites this paper
• Positive allosteric modulation of CB1 suppresses pathological pain without producing tolerance or dependence

  2018cites this paper
• Disruption of nNOS–NOS1AP protein–protein interactions suppresses neuropathic pain in mice

  2018cites this paper
• PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD

  2018cites this paper
• ZLc002, a putative small-molecule inhibitor of nNOS interaction with NOS1AP, suppresses inflammatory nociception and chemotherapy-induced neuropathic pain and synergizes with paclitaxel to reduce tumor cell viability

  2018cites this paper
• Disrupting interaction of PSD‐95 with nNOS attenuates hemorrhage‐induced thalamic pain

  2018cites this paper
• Brain-Permeant and -Impermeant Inhibitors of Fatty Acid Amide Hydrolase Synergize with the Opioid Analgesic Morphine to Suppress Chemotherapy-Induced Neuropathic Nociception Without Enhancing Effects of Morphine on Gastrointestinal Transit

  2018cites this paper
• Targeting the NMDA receptor/NO signalling pathway following L-α aminoadipic acid-induced astrocytic impairment and associated changes in the structural plasticity of neurons

  2018cites this paper
• Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat

  2017cites this paper
• Activation of the NMDA receptor–neuronal nitric oxide synthase pathway within the ventral bed nucleus of the stria terminalis mediates the negative affective component of pain

  2017influential citation
• Small molecule inhibitors of PSD95-nNOS protein-protein interactions suppress formalin-evoked Fos protein expression and nociceptive behavior in rats.

  2017influential citation
• Efficient Binding of the NOS1AP C-Terminus to the nNOS PDZ Pocket Requires the Concerted Action of the PDZ Ligand Motif, the Internal ExF Site and Structural Integrity of an Independent Element

  2017influential citation
• Targeting PSD-95 as a Novel Approach in the Treatment of Stroke

  2017cites this paper
• Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.

  2017cites this paper
• ZL006, a small molecule inhibitor of PSD-95/nNOS interaction, does not induce antidepressant-like effects in two genetically predisposed rat models of depression and control animals

  2017cites this paper
• 2‐methoxyestradiol impacts on amino acids‐mediated metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor

  2017cites this paper
• MGE-derived nNOS+ interneurons promote fear acquisition in nNOS-/- mice.

  2017cites this paper
• Behavioural Brain Research

  2016cites this paper
• Employment of Molecularly Imprinted Polymers to High-Throughput Screen nNOS-PSD-95 Interruptions: Structure and Dynamics Investigations on Monomer-Template Complexation.

  2016cites this paper
• Anti-nociceptive effects of Paecilomyces hepiali via multiple pathways in mouse models.

  2016cites this paper
• Metabolic investigation on ZL006 for the discovery of a potent prodrug for the treatment of cerebral ischemia.

  2016cites this paper
• Effects of the dimeric PSD-95 inhibitor UCCB01-144 in mouse models of pain, cognition and motor function.

  2016cites this paper
• Protection of neuronal cells from excitotoxicity by disrupting nNOS-PSD95 interaction with a small molecule SCR-4026.

  2016cites this paper
• Calcium channels contribute to albiflorin-mediated antinociceptive effects in mouse model.

  2016cites this paper
• Source memory in rats is impaired by an NMDA receptor antagonist but not by PSD95-nNOS protein-protein interaction inhibitors.

  2016cites this paper
• Antidepressant, anxiolytic and anti-nociceptive activities of ethanol extract of Steudnera colocasiifolia K. Koch leaves in mice model

  2015cites this paper
• Patent Highlights June-July 2015.

  2015cites this paper